| 1 |
34626387 | Chemical Approaches to Prepare Modified Heparin and Heparosan Polymers for Biological Studies. | 2022 |
1 |
| 2 |
34768285 | Antithrombin protects against Plasmodium falciparum histidine-rich protein II-mediated inflammation and coagulation. | 2022 Feb 8 |
1 |
| 3 |
34927362 | The functional role of the autolysis loop in the regulation of factor X upon hemostatic response. | 2022 Mar |
1 |
| 4 |
35124550 | Miniaturized antithrombin III affinity monolithic columns coupled to TOF-MS for the selective capture and release of fondaparinux a high affinity antithrombin III ligand. | 2022 May 1 |
1 |
| 5 |
35605639 | Mixing study to diagnose heparin-resistance caused by functional antithrombin deficiency. | 2022 May 23 |
1 |
| 6 |
32536326 | Application of goal-directed therapy for the use of concentrated antithrombin for heparin resistance during cardiac surgery. | 2021 Mar |
9 |
| 7 |
32650697 | Antithrombin use during pediatric cardiac extracorporeal membrane oxygenation admission: insights from a national database. | 2021 Mar |
1 |
| 8 |
32829961 | Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness. | 2021 Jan |
1 |
| 9 |
32920809 | Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency. | 2021 Feb |
3 |
| 10 |
33176060 | Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity. | 2021 Feb |
5 |
| 11 |
33187852 | Successful Antithrombin Administration in Andexanet Alfa-Associated Heparin Resistance. | 2021 Mar |
1 |
| 12 |
33343739 | [COVID-19 and the kidneys-Clinical aspects]. | 2021 |
1 |
| 13 |
33528157 | Antithrombin Dose Optimization in Extracorporeal Membrane Oxygenation in Infants. | 2021 Oct 1 |
2 |
| 14 |
33601159 | Structural characterization of fondaparinux interaction with per-6-amino-beta-cyclodextrin: An NMR and MS study. | 2021 Apr 15 |
1 |
| 15 |
33738401 | Ilio-femoral venous thrombosis with hereditary antithrombin deficiency: a case report of rare thrombotic disease and successful treatment with catheter directed thrombolysis. | 2021 Feb |
1 |
| 16 |
33822598 | Paramount Importance of Core Conformational Changes for Heparin Allosteric Activation of Antithrombin. | 2021 Apr 20 |
2 |
| 17 |
33860518 | Factor XI as a Target for New Anticoagulants. | 2021 Apr |
1 |
| 18 |
33917853 | Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods. | 2021 Apr 8 |
2 |
| 19 |
33929278 | Clot activators and anticoagulant additives for blood collection. A critical review on behalf of COLABIOCLI WG-PRE-LATAM. | 2021 May |
1 |
| 20 |
34061194 | Off Target: Case Report of Heparin Resistance in a Neurosurgical Intensive Care Unit Patient. | 2021 Jun 1 |
1 |
| 21 |
34067120 | Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells. | 2021 May 7 |
1 |
| 22 |
34513101 | Treatment of Homozygous Type II Antithrombin Heparin-Binding Site Deficiency in Pregnancy. | 2021 |
1 |
| 23 |
34743814 | SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate. | 2021 Dec 15 |
1 |
| 24 |
34754684 | Adequate Antithrombin III Level Predicts Survival in Severe COVID-19 Pneumonia. | 2021 Oct |
2 |
| 25 |
34851773 | Management of heparin resistance due to antithrombin deficiency in a Chinese pregnant woman: a case report. | 2021 Nov |
1 |
| 26 |
34937572 | Coexistence of antithrombin deficiency and suspected inferior vena cava atresia in an adolescent and his mother - case report and clinical implications. | 2021 Dec 22 |
1 |
| 27 |
34939461 | Antithrombin III infusion improves anticoagulation in congenital diaphragmatic hernia patients on extracorporeal membrane oxygenation. | 2021 Dec 23 |
2 |
| 28 |
31686597 | The mechanism of high affinity pentasaccharide binding to antithrombin, insights from Gaussian accelerated molecular dynamics simulations. | 2020 Oct |
5 |
| 29 |
31750755 | Exogenous supplementation of antithrombin III in adult and pediatric patients receiving extracorporeal membrane oxygenation. | 2020 May |
6 |
| 30 |
31894660 | Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH. | 2020 Jan |
1 |
| 31 |
31895135 | Heparin sensitivity and postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass. | 2020 Mar |
2 |
| 32 |
31950133 | The antithrombin binding regions of heparin mediate fetal growth and reduced placental damage in the RUPP model of preeclampsia†. | 2020 Apr 24 |
1 |
| 33 |
31959232 | Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO. | 2020 Jan 20 |
1 |
| 34 |
31977357 | Comparison of Antithrombin III Products in Pediatric Patients Receiving Extracorporeal Membrane Oxygenation. | 2020 Sep/Oct |
1 |
| 35 |
32048330 | Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation. | 2020 Apr |
4 |
| 36 |
32128502 | Successful treatment with rivaroxaban of an extended deep vein thrombosis complicated by pulmonary embolism in a patient with familial antithrombin III deficiency: a case report. | 2020 Feb |
2 |
| 37 |
32228213 | A narrative review of antithrombin use during veno-venous extracorporeal membrane oxygenation in adults: rationale, current use, effects on anticoagulation, and outcomes. | 2020 Sep |
2 |
| 38 |
32347711 | Identification of Protein Recognition Elements within Heparin Chains Using Enzymatic Foot-Printing in Solution and Online SEC/MS. | 2020 Jun 2 |
1 |
| 39 |
32388896 | Qualitative analysis of enzymatic and chemical depolymerized low molecular weight heparins by UHPLC coupled with electrospray ionization quadrupole time-of-flight-mass spectrometry. | 2020 Aug |
1 |
| 40 |
32397894 | When antithrombin substitution strikes back. | 2020 May |
2 |
| 41 |
32402428 | Anticoagulant activity and pleiotropic effects of heparin. | 2020 May |
3 |
| 42 |
32404633 | Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation. | 2020 Sep |
1 |
| 43 |
32452976 | Antithrombin Dosing Guidelines in Children Underestimate Dose Needed for Plasma Level Increase. | 2020 Aug |
1 |
| 44 |
32469847 | Myocardial Infarction with Limb Arterial and Venous Thrombosis in a Patient with Enoxaparin-Induced Thrombocytopenia. | 2020 May 29 |
2 |
| 45 |
32515841 | Degeneracy of the Antithrombin Binding Sequence in Heparin: 2-O-Sulfated Iduronic Acid Can Replace the Critical Glucuronic Acid. | 2020 Sep 10 |
3 |
| 46 |
32718661 | Filter-entrapment enrichment pull-down assay for glycosaminoglycan structural characterization and protein interaction. | 2020 Oct 1 |
1 |
| 47 |
32799002 | Antithrombin Deficiency in Trauma and Surgical Critical Care. | 2020 Dec |
2 |
| 48 |
32907762 | Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity. | 2020 Oct 30 |
1 |
| 49 |
32945907 | Ultraviolet photodissociation of fondaparinux generates signature antithrombin-like 3-O-sulfated -GlcNS3S6S- monosaccharide fragment (Y3/C3). | 2020 Nov |
1 |
| 50 |
32947474 | A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation. | 2020 Nov |
2 |